saka heino Rondedzero yePamusoro Biotech makambani muGermany ayo akarongedzerwa zvichienderana nemari yakazara.
| S / N | Company Name | Mari Yese (FY) | Nhamba ye vashandi |
| 1 | Morphosys Ag | $ Miriyoni 401 | 615 |
| 2 | Brain Biotec Na | $ Miriyoni 45 | 279 |
| 3 | Formycon Ag | $ Miriyoni 42 | 131 |
| 4 | Biofrontera Ag Na | $ Miriyoni 37 | 149 |
| 5 | Vita 34 Ag Na | $ Miriyoni 25 | 116 |
| 6 | Heidelberg Pharma Ag | $ Miriyoni 10 | 84 |
| 7 | Medigene Ag Na | $ Miriyoni 10 | 121 |
| 8 | 4Sc Ag Inh. | $ Miriyoni 3 | 48 |
Morphosys Ag
MorphoSys AG inoshanda seyekutengesa-nhanho biopharmaceutical kambani. Iyo Kambani inotarisa pakutsvaga, kusimudzira, uye kuendesa mishonga yegomarara. MorphoSys inoshandira vatengi pasi rese.
Iyo kambani BRAIN Biotech AG
BRAIN Biotech AG ikambani yetekinoroji, inoita mukuvandudza uye kushambadzira kwebioactives, masikirwo emakomisheni, uye evaridzi enzymes. Inoshanda kuburikidza neBioScience uye BioIndustrial zvikamu.
Chikamu cheBioScience chinoshanda pama enzymes uye ma microorganisms ekuita; uye inodyidzana nevadyidzani vemaindasitiri. Chikamu cheBioIndustrial chinobata neiyo bioproduct uye mabhizinesi ekuzora. Iyo kambani yakavambwa naHolger Zinke, Jüngen Eck, naHans Günter Gassen munaGunyana 22, 1993 uye inotungamirwa muZwingenberg, Germany.
Formycon
Formycon inotungamira, yakazvimiririra yekuvandudza yemhando yepamusoro biopharmaceutical mishonga, kunyanya biosimilars. Iyo kambani inotarisa pakurapa mu ophthalmology, immunology uye pane zvimwe zvakakosha zvisingaperi zvirwere, zvinofukidza kukosha kwese cheni kubva mukuvandudza tekinoroji kusvika kukiriniki chikamu III pamwe nekugadzirira dossiers kubvumidzwa kwekushambadzira.
Nema biosimilas ayo, Formycon iri kuita mupiro mukuru mukupa varwere vakawanda sezvinobvira kuwana mishonga yakakosha uye inokwanisika. Formycon parizvino ine matanhatu biosimilars mukusimudzira. Zvichienderana neruzivo rwayo rwakakura mukugadzirwa kwemishonga yebiopharmaceutical, kambani iyi iri kushandawo mukugadzira mushonga weCCIDID-19 FYB207.
Biofrontera Ag Na
Biofrontera AG ikambani yebiopharmaceutical inoshanda mukuvandudza nekutengeswa kwemishonga yedermatological uye zvizorwa zvekurapa. Iyo Leverkusen-based kambani inovandudza uye inotengesa zvigadzirwa zvitsva zvekurapa, kudzivirira uye kutarisira kweganda.
Zvigadzirwa zvaro zvakakosha zvinosanganisira Ameluz®, mushonga wekunyorerwa kurapa isiri-melanoma gomarara reganda uye vanotangira. Ameluz® yave ichitengeswa muEU kubvira 2012 uye muU.SA kubva muna May 2016. MuEurope, kambani inotengesawo Belixos® dermocosmetic series, chigadzirwa chepamusoro chekuchengetedza ganda rakakuvadzwa. Biofrontera ndeimwe yevashoma veGerman kambani yemishonga kugamuchira chibvumirano chepakati peEuropean uye US mvumo yemushonga wakagadzirwa mumba. Boka reBiofrontera rakavambwa muna 1997 uye rakanyorwa paFrankfurt Stock Exchange (Prime Standard).
Vita 34 Ag Na
Yakatangwa muLeipzig muna 1997 seyekutanga yakavanzika umbilical cord ropa bhangi muEurope, Vita 34 ndeye yakazara-range mupi we cryo-kuchengetedza uye inopa iyo logistics kuunganidza ropa, kugadzirira uye kuchengetwa kwe stem masero kubva mumbilical cord ropa uye tishu.
Masero maseru ndiwo akakosha sosi zvinhu zvekurapa masero ekurapa. Iwo anochengetwa ari mapenyu patembiricha inosvika minus 180 degrees Celsius kuti akwanise kuashandisa mukati mechikamu chekurapa, pazvinenge zvichidikanwa. Vanopfuura vatengi ve230.000 vanobva kuGermany nedzimwe nyika makumi maviri vakatovhura stem cell deposits neVita 20, nokudaro vachipa hutano hwevana vavo.
Heidelberg Pharma Ag
Heidelberg Pharma AG ikambani yebiopharmaceutical inoshanda mumunda weoncology. Iyo kambani yakatarisana nekuvandudzwa kweAntibody Drug Conjugates (ADCs) yekurapa zvirwere zveoncological. Heidelberg Pharma's anodaidzwa kuti ATACs maADCs zvichienderana neiyo ATAC tekinoroji inoshandisa Amanitin sechinhu chinoshanda. The biological mechanism of action yeAmanitin toxin inomiririra nzira itsva yekurapa.
Iyi puratifomu yevaridzi iri kushandiswa kugadzira iyo Kambani yega yekurapa maATACs uye yechitatu-bato kubatana kugadzira akasiyana evanoda kuATAC. Mumiriri anotungamira HDP-101 ndeye BCMA-ATAC kune akawanda myeloma. Vamwe vakagadzirira kusimukira vari HDP-102, CD37 ATAC yeNon-Hodgkin lymphoma uye HDP-103, PSMA ATAC yekenza yeprostate isingarambikirwe nemetastatic castration.
Iyo kambani pamwe nerutsigiro rwayo Heidelberg Pharma Research GmbH iri muLadenburg pedyo neHeidelberg kuGermany. Yakatangwa munaGunyana 1997 seWilex Biotechnology GmbH muMunich uye yakashandurwa kuita WILEX AG muna 2000. Muna 2011, kambani yeHeidelberg Pharma Research GmbH yakatorwa uye mushure mekugadzirisazve, hofisi yakanyoreswa yeWILEX AG yakatamiswa kubva kuMunich kuenda kuLadenburg uye Zita rekambani yakashandurwa kuita Heidelberg Pharma AG.
Iyo inotsigira Heidelberg Pharma GmbH yave kunzi Heidelberg Pharma Research GmbH. Iyo kambani Heidelberg Pharma AG inowanikwa mu Frankfurt Stock Exchange.
